Scorpion Therapeutics Funding & Investors
Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.
scorpiontx.comTotal Amount Raised: $420,000,000
Scorpion Therapeutics Funding Rounds
Series C
$150,000,000
Series C Investors
Frazier Life Sciences ManagementLightspeed Venture PartnersOmega Fund ManagementOrbiMed AdvisorsWoodline PartnersAbingworthWellington ManagementWillett AdvisorsVida VenturesNextech InvestCasdin CapitalAtlas VentureLogos CapitalFidelity InvestmentsSurveyor CapitalBoxer CapitalEcoR1 CapitalInvus GroupSeries B
$162,000,000
Series B Investors
Boxer CapitalEcoR1 CapitalVida VenturesAbingworthWoodline PartnersAtlas VentureWellington ManagementLogos CapitalInvus GroupJanus Henderson InvestorsOmega Fund ManagementNextech InvestOrbiMed AdvisorsCasdin CapitalSurveyor CapitalSeries A
$108,000,000
Series A Investors
Atlas VentureOmega Fund ManagementVida VenturesAbingworthPartners HealthCare InnovationMass General Brigham
Funding info provided by Diffbot.